Literature DB >> 9561779

Functional heterogeneity of colonic adenocarcinoma mucins for inhibition of Entamoeba histolytica adherence to target cells.

M U Göttke1, K Keller, A Belley, R M Garcia, M A Hollingsworth, D R Mack, K Chadee.   

Abstract

Mucins secreted from the gastrointestinal epithelium from the basis of the adherent mucus layer which is the host's first line of defense against invasion by Entamoeba histolytica. Galactose and N-acetyl-D-galactosamine residues of mucins specifically inhibit binding of the amebic 170 kDa heavy subunit Gal-lectin to target cells, an absolute prerequisite for pathogenesis. Herein we characterized the secretory mucins isolated from the human colon and from three human colonic adenocarcinoma cell lines: two with goblet cell-like (LS174T and T84) and one with absorptive cell-like morphology (Caco-2). By Northern blot analysis the intestinal mucin genes MUC2 and MUC3 were constitutively expressed by confluent LS174T and Caco-2 cells, whereas T84 cells only transcribed MUC2 and not MUC3 mRNA. 3H-glucosamine and 3H-threonine metabolically labeled proteins separated as high M, mucins in the void (Vo > 10(6) Da) of Sepharose-4B column chromatography and remained in the stacking gel of SDS-PAGE as depicted by fluorography. All mucin preparations contained high amounts of N-acetyl-glucosamine, galactose, N-acetyl-galactosamine, fucose and sialic acid, saccharides typical of the O-linked carbohydrate side chains. Mucin samples from the human colon and from LS174T and Caco-2 cells inhibited E. histolytica adherence to chinese hamster ovary cells, whereas mucins from T84 cells did not. These results suggest that genetic heterogeneity and/or posttranslational modification in glycosylation of colonic mucins can affect specific epithelial barrier function against intestinal pathogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561779     DOI: 10.1111/j.1550-7408.1998.tb04519.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  6 in total

1.  A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target.

Authors:  Chen He; George P Nora; Eric L Schneider; Iain D Kerr; Elizabeth Hansell; Ken Hirata; David Gonzalez; Mohammed Sajid; Sarah E Boyd; Petr Hruz; Eduardo R Cobo; Christine Le; Wei-Ting Liu; Lars Eckmann; Pieter C Dorrestein; Eric R Houpt; Linda S Brinen; Charles S Craik; William R Roush; James McKerrow; Sharon L Reed
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

Review 2.  Pathogenesis of intestinal amebiasis: from molecules to disease.

Authors:  M Espinosa-Cantellano; A Martínez-Palomo
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Sialic acid-dependent attachment of mucins from three mouse strains to Entamoeba histolytica.

Authors:  Kentaro Kato; Yasuhiro Takegawa; Katherine S Ralston; Carol A Gilchrist; Shinjiro Hamano; William A Petri; Yasuro Shinohara
Journal:  Biochem Biophys Res Commun       Date:  2013-05-31       Impact factor: 3.575

4.  Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression.

Authors:  Rita Pinto; Lars Hansen; John Hintze; Raquel Almeida; Sylvester Larsen; Mehmet Coskun; Johanne Davidsen; Cathy Mitchelmore; Leonor David; Jesper Thorvald Troelsen; Eric Paul Bennett
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

5.  Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation.

Authors:  Nazanin Navabi; Michael A McGuckin; Sara K Lindén
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

6.  Intestinal Colonization Traits of Pandemic Multidrug-Resistant Escherichia coli ST131.

Authors:  Sohinee Sarkar; Melanie L Hutton; Dimitrios Vagenas; Rinaldo Ruter; Stephanie Schüller; Dena Lyras; Mark A Schembri; Makrina Totsika
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.